(Total Views: 213)
Posted On: 02/24/2018 7:47:47 PM
Post# of 72441
Welcome 1400. To answer your question: no, this company does not have one blockbuster.
It has THREE.
The CEO has been extremely frugal -- we've gotten 3 drugs into Phase 2 (and one drug has multiple indications -- Brilacidin for Oral Mucositis, and for Ulcerative Proctitis, and as an antibiotic) with MUCH less dilution than other small biotechs typically have with just one drug.
It has THREE.
The CEO has been extremely frugal -- we've gotten 3 drugs into Phase 2 (and one drug has multiple indications -- Brilacidin for Oral Mucositis, and for Ulcerative Proctitis, and as an antibiotic) with MUCH less dilution than other small biotechs typically have with just one drug.
(2)
(0)Scroll down for more posts ▼
